Found 10 matching trials
Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients PHASE2 The purpose of this study is to gather information on the safety and immuno...
Show More Location
Alabama Vaccine Research Clinic; University of Alabama at Birmingham
Learn More & Join Trial
Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission PHASE1 This is a phase I, randomized, open-label trial to investigate the safety o...
Show More Location
Thai Red Cross AIDS Research Centre (TRCARC)
Learn More & Join Trial
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients PHASE1 The purpose of this study is to gather information on the safety and immuno...
Show More Location
Indiana University School of Medicine
Learn More & Join Trial
Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults PHASE1 A multicenter, randomized, parallel-group, placebo-controlled, double-blind...
Show More Location
UCLA CARE (Center for AIDs Research and Education)
Learn More & Join Trial
Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study) PHASE2 This is an open label study to evaluate the safety and immune response to a...
Show More Location
KAVI - Institute of Clinical Research
Learn More & Join Trial
An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients PHASE2 The objective of the study is to compare two doses of MVA-nef vs. MVA-BN to...
Show More Location
University of Erlangen
Learn More & Join Trial
Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults PHASE2 The purpose of this study is to assess the safety, tolerability and immunog...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of Long-term Immunogenicity of a Boost Dose of MVA-BN Vaccine N/A This study is to evaluate the long-term immunogenicity of a boost dose of M...
Show More Location
CIC 1417Cochin-Pasteur
Learn More & Join Trial
An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC PHASE2 This is an open-label, phase 2, immunogenicity and safety trial of the MVA-...
Show More Status
Active Not Recruiting
Location
Centre Hospitalier Kabinda
Learn More & Join Trial
Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection PHASE2 The main purpose of this clinical trial is to generate additional safety da...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial